Oxford BioDynamics' EpiSwitch® Orion Platform Identifies Common 3D Regulatory Networks Across Five Major Fatigue-Related Diseases in Peer-Reviewed Research

Oxford BioDynamics' EpiSwitch® Orion Platform Identifies Common 3D Regulatory Networks Across Five Major Fatigue-Related Diseases in Peer-Reviewed Research →

Oxford BioDynamics Plc (AIM: OBD), the Oxford-based global biotechnology firm, has revealed the publication of a peer-reviewed study in the Journal of Translational Medicine. The study demonstrates that its cloud-based EpiSwitch® Orion plat…